Immunoglobulin (Ig)D-kappa multiple myeloma (MM) is a rare neoplastic disease characterized by an aggressive and rapidly progressing course, which constitutes only a very small proportion of all MM cases. In the present report, the clinical case of a 51-year-old Caucasian woman diagnosed with IgD-kappa MM is described. The patient underwent different chemotherapeutic treatments subsequently to a single autologous stem cell transplantation. Despite the inherent difficulty of monitoring IgD levels and performing serum immunofixation electrophoresis, the clinical outcome of the patient was almost uniquely monitored by measuring the levels of kappa and lambda free light chains (FLCs) and total heavy chain IgD. The data suggest the non-invasive potential and usefulness of FLCs evaluation for early detection of stringent complete remission, follow-up and early detection of disease relapse. In addition, this diagnostic procedure has successfully been employed for the therapeutic monitoring of the present patient, and may represent a very helpful, non-invasive tool for the follow-up of IgD myeloma patients without the requirement of serial bone marrow aspirate.

De Santis, E., Serena, M., Iole, C., Francesco, P., Zuppi, C., Fabrizio, M., Laura, C., Giovanni, C., Follow-up of IgD-kappa multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report, <<ONCOLOGY LETTERS>>, 2016; 12 (3): 1884-1888. [doi:10.3892/ol.2016.4869] [http://hdl.handle.net/10807/94593]

Follow-up of IgD-kappa multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report

De Santis, Elena
Primo
;
Zuppi, Cecilia;
2016

Abstract

Immunoglobulin (Ig)D-kappa multiple myeloma (MM) is a rare neoplastic disease characterized by an aggressive and rapidly progressing course, which constitutes only a very small proportion of all MM cases. In the present report, the clinical case of a 51-year-old Caucasian woman diagnosed with IgD-kappa MM is described. The patient underwent different chemotherapeutic treatments subsequently to a single autologous stem cell transplantation. Despite the inherent difficulty of monitoring IgD levels and performing serum immunofixation electrophoresis, the clinical outcome of the patient was almost uniquely monitored by measuring the levels of kappa and lambda free light chains (FLCs) and total heavy chain IgD. The data suggest the non-invasive potential and usefulness of FLCs evaluation for early detection of stringent complete remission, follow-up and early detection of disease relapse. In addition, this diagnostic procedure has successfully been employed for the therapeutic monitoring of the present patient, and may represent a very helpful, non-invasive tool for the follow-up of IgD myeloma patients without the requirement of serial bone marrow aspirate.
Inglese
De Santis, E., Serena, M., Iole, C., Francesco, P., Zuppi, C., Fabrizio, M., Laura, C., Giovanni, C., Follow-up of IgD-kappa multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report, <<ONCOLOGY LETTERS>>, 2016; 12 (3): 1884-1888. [doi:10.3892/ol.2016.4869] [http://hdl.handle.net/10807/94593]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/94593
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact